Table 2.
Concentration (μg/placa) |
TA 100 Mean revertants/plate ± SD |
TA 98 Mean revertants/plate ± SD |
||
---|---|---|---|---|
−S9 | +S9 | −S9 | +S9 | |
0a | 58.33 ± 16.56 | 62.60 ± 15.1 | 25.67 ± 3.79 | 38.33 ± 2.52 |
50 | 54.33 ± 5.13 | 64.10 ± 10.5 | 26.00 ± 4.36 | 38.67 ± 11.85 |
150 | 45.33 ± 4.73 | 60.04 ± 13.7 | 28.67 ± 7.64 | 45.67 ± 8.33 |
500 | 44.00 ± 2.00 | 60.33 ± 5.77 | 22.00 ± 5.29 | 35.67 ± 20.11 |
1500 | 46.67 ± 2.52 | 70.70 ± 7.37 | 26.00 ± 4.36 | 40.67 ± 8.62 |
5000 | 51.67 ± 3.21 | 67.31 ± 2.52 | 27.00 ± 2.65 | 38.33 ± 2.52 |
NaA1.5b | 480.0 ± 22.6∗∗ | |||
2AF 20b | 2280.0 ± 169.7∗∗ | 3300.0 ± 141.4∗∗ | ||
PA 100b | 992.0 ± 11.3∗∗ |
+S9: with hepatic fraction S9; −S9: without hepatic fraction S9.
aNegative control, dimethyl sulfoxide (DMSO).
bPositive controls. NaA: sodium azide; 2AF: 2-aminofluorene; PA: pichrolonic acid.
**P < 0.01 (Student's t-test).